The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol, and Δ9-tetrahydrocannabivarin. Pertwee, R G
British Journal of Pharmacology. 2008 Jan, 153(2): 199-215.

Cannabis improves symptoms of ADHD. Strohbeck-Kuehner, Peter, et al.
Cannabinoids. 2008, 3(1): 1-3.

Gut modulatory, blood pressure lowering, diuretic and sedative activities of cardamom. Gilani, Anwarul Hassan, et al.
Journal of Ethnopharmacology. 2008 Feb 12, 115(3): 463-472 (abstract).

Neuroprotective effects of cannabidiol in endotoxin-induced uvetis: critical role of p38 MAPK activation El-Remessy, A B, et al.
Molecular Vision. 2008, 14: 2190-2203.

Antihyperalgesic effect of a cannabis sativa in a rat model of neuropathic pain: mechanisms involved. Cormelli, F, et al.
Phytotherapeutic Research. 2008, 22(8): 1017-1024 (abstract).

Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action. Zuardi, Antonio Waldo
Revista Brasileira de Psiquiatria. 2008, Sep, 30(3).

Cannabidiol, extracted from cannabis sativa selectively inhibits hypermotility in mice. Capasso, R, et al.
British Journal of Pharmacology. 2008 May 12, 154(5): 1001-1008.

A randomized, placebo-controlled, crossover trial cannabis cigarettes in neuropathic pain. Wilsey, B et al.
Journal of Pain. 2008, June 9(6): 506-521.

Cannabinoids in the management of difficult to treat pain. Russo, Ethan B
Therapeutics and Clinical Risk Management. 2008, 4(1): 245-259.

Influence on cannabis use on severity of hepatitis C disease. Ishida, Julie H, et al.
Clinical Gastroenterology and Hepatology. 2008 Jan, 6(1): 69-75.


10% OFF


Be the first to learn about our new product additions, events and special promotions.